ReviewTherapeutic advances in respiratory disease

Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.

Corrado Pelaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.